ProCE Banner Activity

Pharmacologic and Administration Considerations for CGRP-Targeted Medications: New and Emerging Preventive Options

Slideset

This faculty-curated slideset covers new and emerging CGRP-targeted medications to prevent migraine.

Released: April 05, 2024

Expiration: April 04, 2025

Share

Faculty

Nada Hindiyeh

Nada Hindiyeh, MD, FAHS

Director, Headache Neurology
Metrodora Institute
Chief Medical Officer
Haven Headache and Migraine Center
West Valley City, Utah

Provided by

Provided by Clinical Care Options, LLC

ProCE Banner

Supporters

Supported by educational grants from AbbVie Inc., Lundbeck and Pfizer, Inc.

AbbVie Inc.

Lundbeck

Pfizer, Inc.